Search results for "ffpe challenges"

With its unique combination of low-cost and high accuracy, ppmSeq marks a real breakthrough in sequencing technology

As Gram-negative resistance becomes more complex, laboratories and clinicians are working together to turn susceptibility data into more targeted treatment decisions

Dr. Ronan Chaligné, Head of the Single-Cell Analytics Innovation Laboratory, discusses advances in single-cell methods advancing cancer research

Multiplex amplicon panels for Illumina® platform.

Uniting industry leaders to foster strategic partnerships, drive innovation, and unlock the potential of wound care products and services

At CYTO 2022, BennuBio showcased its latest  large particle flow cytometer that aims to simplify the 3D cell model workflow

Delve into our new content hub, highlighting an integrated, intuitive and intelligent gas chromatography portfolio

Dr. Thomas H. Walter, of Waters Corporation, looks back at the trials, tribulations, and triumphs that paved the way to today’s advanced separation technologies

Designed for use in decentralized, CLIA-waived settings, the test has been analytically verified in a study to deliver results comparable to standard laboratory methods

New collaborative study has directly mapped what happens inside liquid crystals when they are deformed

Experienced clinical immunologist and global life science executive to support progression of lead candidate through the clinic

A complete system for lead-to-answer screening in ion channel assays

Watch this on-demand webinar to learn effective strategies to ensure optimal antibody performance in multiplex IHC assays

LabVantage LIMS 8.7 Portal provides external customer self-service access to LIMS while maintaining the laboratory’s data security

Discover how advances in dried blood spot testing are advancing biomarker analysis and sample collection

Find out how research at HUB Organoids is paving the way for more effective cancer therapeutics

A look at some of the available companion diagnostics for breast, lung and colorectal cancer